Instruments and Solutions to Accelerate Cell Therapy Development
Innovative approaches to improve in vivo efficacy
Genetically modified immune cell therapies use cells that have been engineered to improve their abilities to fight disease. In the case of cancer, transgenic chimeric antigen receptors (CARs), T cell receptors (TCRs), and other enhancements are designed to improve tumor-specific immunogenicity and to enhance tumor cell killing.
Despite early successes, there are limitations that complicate the development, testing, and manufacturing of cell therapies. These include:
Lack of standard potency assays to measure biological activity and efficacy
Suboptimal tumor cell models and difficulties in solid tumor cell targeting
Challenges in assessing metabolic status to improve immune cell activities
This eBook focuses on the latest instruments, tools, and techniques designed to address these challenges and accelerate immune cell therapy development and testing.
download this free ebook to learn more
LabX.com c/o LabX Media Group
334 King Street, Unit 2, Midland, Ontario, Canada, L4R 3M8
Toll-Free: 888.781.0328 | Phone: 705.528.6888
Email: privacy@labx.com
Copyright © 1995-2023 LabX.com All Rights Reserved.
Designated trademarks and brands are the property of their respective owners.
Use of this website constitutes acceptance of the LabX User Agreement.